Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM)

Bergersen, Lisa; Gauvreau, Kimberlee; Foerster, Susan; Marshall, Audrey C.; McElhinney, Doff B.; Beekman, Robert H.; Hirsch, Russel; Kreutzer, Jacqueline; Balzer, David T.; Vincent, Julie; Hellenbrand, William E.; Holzer, Ralf; Cheatham, John P.; Moore, John W.; Burch, Grant H.; Armsby, Laurie B.; Lock, James E.; Jenkins, Kathy J.

doi:10.1016/j.jcin.2011.05.021

Cited by 149 publications

(107 citation statements)

References 26 publications

(29 reference statements)

Supporting

Mentioning

103

Contrasting

Order By: Relevance

“…Over the course of the study, devices available for percutaneous PDA occlusion varied; thus, a consistent PDA closure algorithm was not feasible. While we intended to describe AEs attributable to the catheterization procedure, we recognize that complications are intimately tied to a variety of patient‐specific variables and the potential bias involved in retrospective analysis 19. Since the present study was conducted at a major academic center, the risk of referral bias is recognized.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Percutaneous Patent Ductus Arteriosus (PDA) Closure in Very Preterm Infants: Feasibility and Complications

Backes

Cheatham

Deyo

et al. 2016

JAHA

Self Cite

110

111

View full text Add to dashboard Cite

BackgroundPercutaneous closure of patent ductus arteriosus (PDA) in term neonates is established, but data regarding outcomes in infants born very preterm (<32 weeks of gestation) are minimal, and no published criteria exist establishing a minimal weight of 4 kg as a suitable cutoff. We sought to analyze outcomes of percutaneous PDA occlusion in infants born very preterm and referred for PDA closure at weights <4 kg.Methods and ResultsRetrospective analysis (January 2005–January 2014) was done at a single pediatric center. Procedural successes and adverse events were recorded. Markers of respiratory status (need for mechanical ventilation) were determined, with comparisons made before and after catheterization. A total of 52 very preterm infants with a median procedural weight of 2.9 kg (range 1.2–3.9 kg) underwent attempted PDA closure. Twenty‐five percent (13/52) of infants were <2.5 kg. Successful device placement was achieved in 46/52 (88%) of infants. An adverse event occurred in 33% of cases, with an acute arterial injury the most common complication. We observed no association between weight at time of procedure and the risk of an adverse event. No deaths were attributable to the PDA closure. Compared to precatheterization trends, percutaneous PDA closure resulted in improved respiratory status, including less exposure to mechanical ventilation (mixed effects logistic model, P<0.01).ConclusionsAmong infants born very preterm, percutaneous PDA closure at weights <4 kg is generally safe and may improve respiratory health, but risk of arterial injury is noteworthy. Randomized clinical trials are needed to assess clinically relevant differences in outcomes following percutaneous PDA closure versus alternative (surgical ligation) management strategies.

show abstract

Section: Discussionmentioning

confidence: 99%

“…The indications for the procedure and any associated congenital heart defects were recorded. Adverse events (AEs) during and after catheterization were classified using a standard format 19, 20…”

Section: Methodsmentioning

confidence: 99%

Percutaneous Patent Ductus Arteriosus (PDA) Closure in Very Preterm Infants: Feasibility and Complications

Backes

Cheatham

Deyo

et al. 2016

JAHA

Self Cite

110

111

View full text Add to dashboard Cite

show abstract

“…Similar concepts have been proposed for application to interventional catheterization and electrophysiological procedures. 140,141 Transparent, public availability of clinical outcomes data is an increasingly important feature of the practice of pediatric cardiovascular medicine. Building on the cooperative spirit of clinical investigators in pediatric cardiovascular research, we also anticipate the growth of learning collaboratives, such as the PHN projects on Collaborative Learning and the Residual Lesion Score.…”

Section: Risk Stratification In Outcomes Measurement Quality Improvementioning

confidence: 99%

Trends in Congenital Heart Disease

2016

View full text Add to dashboard Cite

“…This current IMPACT model builds on previous work and a risk model developed using the Congenital Cardiac Catheterization Project on Outcomes (C3PO) registry. 7 The C3PO Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM) identified threshold values for hemodynamic vulnerability and also helped define and validate the subset of 4 procedural risk groups (ranked from lowest to highest risk) that were incorporated into the current model. Some may question whether we need another pediatric catheterization risk-model.…”

Section: Article See P 1863mentioning

confidence: 99%

Ongoing Evolution of Outcomes Analysis for Pediatric and Congenital Cardiac Catheterization

Hill

Jacobs

2015

Circulation

View full text Add to dashboard Cite

Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM)

Abstract: Using CHARM (Catheterization for Congenital Heart Disease Adjustment for Risk Method) to adjust for case mix complexity should allow comparisons of AE among institutions performing catheterization for congenital heart disease.

Cited by 149 publications

References 26 publications

Percutaneous Patent Ductus Arteriosus (PDA) Closure in Very Preterm Infants: Feasibility and Complications

Percutaneous Patent Ductus Arteriosus (PDA) Closure in Very Preterm Infants: Feasibility and Complications

Trends in Congenital Heart Disease

Ongoing Evolution of Outcomes Analysis for Pediatric and Congenital Cardiac Catheterization

Contact Info

Product

Resources

About